CHEK2 and cerebellar ataxia: Germline mutations in BRCA1/2 occur in approximately 10% of TNBC patients [7], and mutations in further genes involved in the maintenance of genomic integrity and DNA repair, such as ATM (ataxia-telangiectasia), CHEK2 (Checkpoint kinase 2), and TP53 are also common [10,11].